MA28525B1 - Identification d'antigenes autologues ou non autologues impliques dans des maladies auto-immunes - Google Patents

Identification d'antigenes autologues ou non autologues impliques dans des maladies auto-immunes

Info

Publication number
MA28525B1
MA28525B1 MA29378A MA29378A MA28525B1 MA 28525 B1 MA28525 B1 MA 28525B1 MA 29378 A MA29378 A MA 29378A MA 29378 A MA29378 A MA 29378A MA 28525 B1 MA28525 B1 MA 28525B1
Authority
MA
Morocco
Prior art keywords
autologous
identification
autoimmune diseases
antigens involved
involved
Prior art date
Application number
MA29378A
Other languages
English (en)
Inventor
James Rasmussen
Bei Yu
Original Assignee
Peptimmune Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Peptimmune Inc filed Critical Peptimmune Inc
Publication of MA28525B1 publication Critical patent/MA28525B1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/10—Peptides having 12 to 20 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4713—Autoimmune diseases, e.g. Insulin-dependent diabetes mellitus, multiple sclerosis, rheumathoid arthritis, systemic lupus erythematosus; Autoantigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0008—Antigens related to auto-immune diseases; Preparations to induce self-tolerance
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hematology (AREA)
  • Genetics & Genomics (AREA)
  • Rehabilitation Therapy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Diabetes (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Transplantation (AREA)
  • Dermatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
MA29378A 2004-03-11 2006-10-11 Identification d'antigenes autologues ou non autologues impliques dans des maladies auto-immunes MA28525B1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US10/799,005 US7084247B2 (en) 2004-03-11 2004-03-11 Identification of self and non-self antigens implicated in autoimmune diseases

Publications (1)

Publication Number Publication Date
MA28525B1 true MA28525B1 (fr) 2007-04-03

Family

ID=34920407

Family Applications (1)

Application Number Title Priority Date Filing Date
MA29378A MA28525B1 (fr) 2004-03-11 2006-10-11 Identification d'antigenes autologues ou non autologues impliques dans des maladies auto-immunes

Country Status (17)

Country Link
US (2) US7084247B2 (fr)
EP (1) EP1732595A2 (fr)
JP (1) JP2007528422A (fr)
KR (1) KR20070026450A (fr)
CN (1) CN1942202A (fr)
AP (1) AP2006003735A0 (fr)
AU (1) AU2005221712A1 (fr)
BR (1) BRPI0508633A (fr)
CA (1) CA2559065A1 (fr)
EA (1) EA200601671A1 (fr)
IL (1) IL177961A0 (fr)
MA (1) MA28525B1 (fr)
MX (1) MXPA06010364A (fr)
NO (1) NO20064610L (fr)
TN (1) TNSN06273A1 (fr)
WO (1) WO2005087261A2 (fr)
ZA (1) ZA200607552B (fr)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7084247B2 (en) * 2004-03-11 2006-08-01 Peptimmune, Inc. Identification of self and non-self antigens implicated in autoimmune diseases
DE602006015837D1 (de) * 2005-10-14 2010-09-09 Janssen Pharmaceutica Nv Formulierungen von tipifarnib zur intravenösen verabreichung
ATE461208T1 (de) * 2006-01-17 2010-04-15 Organon Nv Selektive enzymatische hydrolyse von c-terminalen tert-butyl-peptidestern
JP2009536157A (ja) * 2006-04-13 2009-10-08 ペプチミューン，インコーポレイテッド エピトープ透過性の指向された拡張を介した指向性配列ポリマー組成物の設計方法および合成方法
JP2009069050A (ja) * 2007-09-14 2009-04-02 Nec Corp 化合物のカラム担体への固定化方法
AP3467A (en) * 2007-10-16 2015-11-30 Peptimmune Inc Methods for designing and preparing vaccines comprising directed sequence polymer compositions via the directed expansion of epitopes
AU2009236583B2 (en) * 2008-04-17 2015-07-16 Declion Holdings Llc Design and synthesis of directed sequence polymer compositions and antibodies thereof for the treatment of protein conformational disorders
EP2186833B8 (fr) 2008-11-17 2012-08-08 Borealis AG Procédé multi-niveaux pour produire du polyéthylène avec une formation de gel diminuée
CA2761907A1 (fr) * 2009-05-14 2010-11-18 Oatmeal Biotechnologies Group, L.L.C. Technologies de plateforme pour des maladies se produisant spontanement
GB201112806D0 (en) * 2011-07-26 2011-09-07 Bauer Johann Use of epitopes inducing specific tolerance for the prevention of tissue rejection
EP2570455A1 (fr) 2011-09-16 2013-03-20 Borealis AG Composition de polyéthylène avec large distribution de poids moléculaire et homogénéité améliorée
EP2599828A1 (fr) 2011-12-01 2013-06-05 Borealis AG Composition de polyéthylène multimodale pour la production des tuyaux avec une résistance améliorée de croissance lente des fissures
US11458199B2 (en) * 2012-08-21 2022-10-04 Opko Pharmaceuticals, Llc Liposome formulations
ES2604934T3 (es) 2012-11-09 2017-03-10 Abu Dhabi Polymers Company Limited (Borouge) Composición polimérica que comprende una mezcla de un polietileno multimodal y un polímero de etileno adicional adecuado para la fabricación de un tubo de riego por goteo
EP2730611B1 (fr) 2012-11-09 2017-01-04 Abu Dhabi Polymers Company Limited (Borouge) Tuyau d'irrigation au goutte-à-goutte comprenant une composition polymère avec une résine à base de polyéthylène multimodal
EP2740761B1 (fr) 2012-12-05 2016-10-19 Borealis AG Composition de polyéthylène présentant un équilibre amélioré de résistance à la propagation des fissures lentes, la résistance aux chocs et une résistance à la pression des tuyaux pour des applications de tuyaux
EP2860204B1 (fr) 2013-10-10 2018-08-01 Borealis AG Composition de polyéthylène pour applications de tuyau
EP2860201A1 (fr) 2013-10-10 2015-04-15 Borealis AG Polyéthylène résistant aux températures élevées et son procédé de production
EP2860200B1 (fr) 2013-10-10 2017-08-02 Borealis AG Composition de polyéthylène pour tuyau et applications de revêtement de tuyau
PL2860202T3 (pl) 2013-10-10 2018-11-30 Borealis Ag Polietylen odporny na wysoką temperaturę i sposób jego wytwarzania
US10801070B2 (en) 2013-11-25 2020-10-13 The Broad Institute, Inc. Compositions and methods for diagnosing, evaluating and treating cancer
US11725237B2 (en) 2013-12-05 2023-08-15 The Broad Institute Inc. Polymorphic gene typing and somatic change detection using sequencing data
EP4052724A1 (fr) * 2013-12-06 2022-09-07 The Broad Institute Inc. Formulations des vaccins contre la néoplasie
KR20230076867A (ko) 2013-12-20 2023-05-31 더 브로드 인스티튜트, 인코퍼레이티드 신생항원 백신과의 병용 요법
US10301370B2 (en) * 2014-05-02 2019-05-28 The Trustees Of The University Of Pennsylvania Compositions and methods of chimeric autoantibody receptor T cells
EP3234130B1 (fr) 2014-12-19 2020-11-25 The Broad Institute, Inc. Procédé pour profiler le répertoire de récepteurs de cellulles t.
US10975442B2 (en) 2014-12-19 2021-04-13 Massachusetts Institute Of Technology Molecular biomarkers for cancer immunotherapy
AU2016264623B2 (en) 2015-05-20 2022-06-30 Dana-Farber Cancer Institute, Inc. Shared neoantigens
US11549149B2 (en) 2017-01-24 2023-01-10 The Broad Institute, Inc. Compositions and methods for detecting a mutant variant of a polynucleotide
EP3647645A1 (fr) 2018-10-31 2020-05-06 Borealis AG Composition de polyéthylène pour tuyaux résistant à une haute pression
US20210317290A1 (en) 2018-10-31 2021-10-14 Borealis Ag Polyethylene composition for high pressure resistant pipes with improved homogeneity
AU2019388183B2 (en) 2018-11-28 2022-03-24 Abu Dhabi Polymers Co. Ltd (Borouge) L.L.C. Polyethylene composition for film applications
EP4004066A1 (fr) 2019-07-22 2022-06-01 Abu Dhabi Polymers Co. Ltd (Borouge) Llc. Composition de polyéthylène multimodal catalysé en un seul site
EP4019583B1 (fr) 2020-12-28 2024-04-10 ABU DHABI POLYMERS CO. LTD (BOROUGE) - Sole Proprietorship L.L.C. Composition de polyéthylène pour des applications de films à résistance et rigidité améliorées

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4973577A (en) * 1986-04-04 1990-11-27 The Salk Institute For Biological Studies FSH-releasing peptides
US5130297A (en) * 1988-06-23 1992-07-14 Anergen, Inc. Conjugates useful in ameliorating autoimmunity MHC-II-peptide
US5260422A (en) 1988-06-23 1993-11-09 Anergen, Inc. MHC conjugates useful in ameliorating autoimmunity
US5194425A (en) * 1988-06-23 1993-03-16 Anergen, Inc. Mhc-mediated toxic conjugates useful in ameliorating autoimmunity
WO1990008161A1 (fr) 1989-01-12 1990-07-26 The Blood Center Of Southeastern Wisconsin Modulation par peptides mediateurs de la reconnaissance d'antigenes par les lymphocytes t, utilises comme moyens d'affectation de reactions immunitaires
CA2106567A1 (fr) 1991-03-22 1992-09-23 William V. Williams Methode de modulation de la reponse des cellules t de mammiferes
AU3178393A (en) 1991-11-27 1993-06-28 United States Of America, Represented By The Secretary, Department Of Health And Human Services, The Nucleotide and amino acid sequence of pemphigus vulgaris antigen and methods of use
US5719064A (en) 1992-08-31 1998-02-17 Oklahoma Medical Research Foundation Peptide diagnostics and therapeutics for spondyloarthropathies
WO1994006828A1 (fr) 1992-09-11 1994-03-31 Washington University Peptides rendant tolerant les lymphocytes t et leurs compositions
EP0726708A1 (fr) 1993-11-05 1996-08-21 Pathogenesis Corporation Sclerose en plaques associee a un virus: traitements, prevention et diagnostic
US6329499B1 (en) * 1994-11-18 2001-12-11 Neurocrine Biosciences, Inc. Methods for treatment of multiple sclerosis using peptide analogues of human myelin basic protein
US5874531A (en) * 1995-03-07 1999-02-23 President And Fellows Of Harvard College Identification of self and non-self antigens implicated autoimmune disease
AU767185B2 (en) * 1998-03-23 2003-11-06 President And Fellows Of Harvard College Synthesis of compounds and libraries of compounds
US6294192B1 (en) * 1999-02-26 2001-09-25 Lipocine, Inc. Triglyceride-free compositions and methods for improved delivery of hydrophobic therapeutic agents
US7084247B2 (en) * 2004-03-11 2006-08-01 Peptimmune, Inc. Identification of self and non-self antigens implicated in autoimmune diseases

Also Published As

Publication number Publication date
US20050202034A1 (en) 2005-09-15
AP2006003735A0 (en) 2006-10-31
ZA200607552B (en) 2008-05-28
WO2005087261A2 (fr) 2005-09-22
MXPA06010364A (es) 2007-03-07
IL177961A0 (en) 2006-12-31
US7084247B2 (en) 2006-08-01
EA200601671A1 (ru) 2007-02-27
CA2559065A1 (fr) 2005-09-22
TNSN06273A1 (en) 2007-12-03
US20060159672A1 (en) 2006-07-20
BRPI0508633A (pt) 2007-08-07
EP1732595A2 (fr) 2006-12-20
WO2005087261A3 (fr) 2005-12-08
AU2005221712A1 (en) 2005-09-22
CN1942202A (zh) 2007-04-04
NO20064610L (no) 2006-12-04
KR20070026450A (ko) 2007-03-08
JP2007528422A (ja) 2007-10-11

Similar Documents

Publication Publication Date Title
MA28525B1 (fr) Identification d'antigenes autologues ou non autologues impliques dans des maladies auto-immunes
FR22C1052I2 (fr) Anticorps anti-cd19 humanises et leur utilisation dans le traitement des tumeurs, de la transplantation et des maladies auto-immunes
ATE480567T1 (de) Hochkonzentrierter antikörper und proteinformulierungen
DE60334460D1 (de) Antikörper spezifisch für das tau-protein des zentralen nervensystems
MA28565B1 (fr) Proteines hybrides d'albumine
ME02002B (me) Humana monoklonska antitela prema proteinskoj tirozin kinazi 7 (ptk 7) i njihova upotreba
HK1102012A1 (en) Antibodies and molecules derived therefrom that bind to steap-1 proteins
EP1599228A4 (fr) Anticorps modifies diriges contre un antigene membranaire specifique de la prostate
MX2007008017A (es) Polipeptidos que se ligan a br3 y usos de los mismos.
EP1610818A4 (fr) Anticorps modifies diriges contre un antigene membranaire specifique de la prostate
EA200700175A1 (ru) Композиции и способы лечения воспалительных заболеваний
IL182422A0 (en) Prion protein binding materials and methods of use
DE602005012555D1 (de) Künstliches protein zur absoluten quantifizierung von proteinen und verwendungen davon
DK1844074T3 (da) Humane antistoffer og proteiner
WO2008080045A3 (fr) Antagonistes du dr6 et leurs utilisations dans le traitement des troubles neurologiques
EA201000424A1 (ru) Антитела к il-23
EP1951892A4 (fr) Traitement par anticorps de la maladie d'alzheimer et des maladies connexes
DE602005009729D1 (de) System zur zubereitung von getränken
MA29067B1 (fr) Protéines de fusion de RAGE et méthodes d'utilisation
CR20110557A (es) Proteinas de fusion rage y metodos de empleo
ATE366317T1 (de) Herstellung von peptiden und proteinen durch anhäufung in vom endoplasmatischen reticulum abgeleiteten proteinkörpern
MA33381B1 (fr) Proteine de liaison a il-13
BRPI0413495A (pt) reagentes de peptìdeos especìficos para prìons e seus usos
BRPI0514124A (pt) anticorpos monoclonais humanos contra a il-4 humana
IL179332A0 (en) Antibodies and related molecules that bind to psca proteins